Warfarin resistance and enteral tube feeding: A vitamin K-independent interaction

Nutrition

Volumn 24, Issue 10, 2008, Pages 1048-1052

  Dickerson, Roland N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; PHENYTOIN; PROPOFOL; QUINOLONE DERIVATIVE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; ARTICLE; DIETARY INTAKE; DRUG BINDING; ENTERIC FEEDING; FOOD DRUG INTERACTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTESTINE ABSORPTION; PRIORITY JOURNAL; TUBE FEEDING; VITAMIN INTAKE;

ANTICOAGULANTS; DRUG INTERACTIONS; DRUG RESISTANCE; ENTERAL NUTRITION; HUMANS; INTERNATIONAL NORMALIZED RATIO; RISK FACTORS; VITAMIN K; WARFARIN;

EID: 50549083811     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.05.015     Document Type: Article

References (19)

1. Bentley D.P., Backhouse G., Hutchings A., Haddon R.L., Spragg B., and Routledge P.A. Investigation of patients with abnormal response to warfarin. Br J Clin Pharmacol 22 (1986) 37-41
2. Howard P.A., and Hannaman K.N. Warfarin resistance linked to enteral nutrition products. J Am Diet Assoc 85 (1985) 713-715
3. Lee M., Schwartz R.N., and Sharifi R. Warfarin resistance and vitamin K. Ann Intern Med 94 (1981) 140-141
4. Parr M.D., Record K.E., Griffith G.L., Zeok J.V., and Todd E.P. Effect of enteral nutrition on warfarin therapy. Clin Pharmacokinet 1 (1982) 274-276
5. Zallman J.A., Lee D.P., and Jeffrey P.L. Liquid nutrition as a cause of warfarin resistance. Am J Hosp Pharm 38 (1981) 1174
6. Schurgers L.J., Shearer M.J., Hamulyak K., Stocklin E., and Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 104 (2004) 2682-2689
7. Food and Nutrition Board Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc (2001), National Academy Press, Washington, DC 162-196
8. Bauer L.A. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 32 (1982) 570-572
9. Healy D.P., Brodbeck M.C., and Clendening C.E. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother 40 (1996) 6-10
10. Kuhn T.A., Garnett W.R., Wells B.K., and Karnes H.T. Recovery of warfarin from an enteral nutrient formula. Am J Hosp Pharm 46 (1989) 1395-1399
11. Penrod L.E., Allen J.B., and Cabacungan L.R. Warfarin resistance and enteral feedings: 2 case reports and a supporting in vitro study. Arch Phys Med Rehabil 82 (2001) 1270-1273
12. Holford N.H. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet 11 (1986) 483-504
13. Dickerson R.N., Garmon W.M., Kuhl D.A., Minard G., and Brown R.O. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Pharmacotherapy 28 (2008) 308-313
14. Martin J.E., and Lutomski D.M. Warfarin resistance and enteral feedings. JPEN 13 (1989) 206-208
15. Petretich D.A. Reversal of Osmolite-warfarin interaction by changing warfarin administration time. Clin Pharmacokinet 9 (1990) 93
16. Lutomski D.M., Palascak J.E., and Bower R.H. Warfarin resistance associated with intravenous lipid administration. JPEN 11 (1987) 316-318
17. MacLaren R., Wachsman B.A., Swift D.K., and Kuhl D.A. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy 17 (1997) 1331-1337
18. Lennon C., Davidson K.W., Sadowski J.A., and Mason J.B. The vitamin K content of intravenous lipid emulsions. JPEN 17 (1993) 142-144
19. Buckley M.S., Goff A.D., and Knapp W.E. Fish oil interaction with warfarin. Ann Pharmacother 38 (2004) 50-52